Literature DB >> 7126411

The influence of oral contraceptives on the metabolism of methaqualone in man.

M Oram, K Wilson, D Burnett.   

Abstract

1 Oral contraceptives were shown to suppress the mid-cycle increase in methaqualone metabolism observed in premenopausal women not receiving oral contraceptive therapy. No women were identified in whom this suppression was not observed. 2 Combined oestrogen-progestogen contraceptives produced the effect in all nine women studied. The effect was also observed in one woman who was receiving progestogen-only contraceptives. 3 The effect of the combined contraceptives was observed within one month of the commencement of the contraceptive therapy. 4 The results emphasise the need to monitor the effect of the menstrual cycle in women not receiving oral contraceptive therapy when the effects of such therapy is studied. 5 These effects are more likely to be the consequence of an inhibition of hormonal control of hepatic metabolic activity by the synthetic steroids than they are to simple inhibition of hepatic metabolism.

Entities:  

Keywords:  Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Endocrine System; Estrogens; Family Planning; Hepatic Effects; Hormones; Metabolic Effects; Oral Contraceptives, Combined--side effects; Oral Contraceptives--side effects; Physiology; Progesterone; Reproductive Control Agents; Steroid Metabolic Effects

Mesh:

Substances:

Year:  1982        PMID: 7126411      PMCID: PMC1427634          DOI: 10.1111/j.1365-2125.1982.tb01989.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

Review 1.  Minipill--a limited alternative for certain women.

Authors:  W Rinehart
Journal:  Popul Rep A       Date:  1975-09

2.  Urinary excretion of c-hydroxy derivatives of methaqualone in man.

Authors:  D Burnett; C N Reynolds; K Wilson; J R Francis
Journal:  Xenobiotica       Date:  1976-02       Impact factor: 1.908

3.  Effect of oral contraceptives on drug metabolism.

Authors:  D E Carter; J M Goldman; R Bressler; R J Huxtable; C D Christian; M W Heine
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

4.  Impairment of human drug metabolism by oral contraceptive steroids.

Authors:  K O'Malley; I H Stevenson; J Crooks
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

5.  Impairment of antipyrine metabolism by low-dose oral contraceptive steroids.

Authors:  D R Abernethy; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-01       Impact factor: 6.875

6.  Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women.

Authors:  M Homeida; M Halliwell; R A Branch
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

7.  Inter- and intra-individual variation in the metabolism of methaqualone in man after a single oral dose.

Authors:  K Wilson; C N Reynolds; D Burnett
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

8.  Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives.

Authors:  R K Roberts; P V Desmond; G R Wilkinson; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1979-06       Impact factor: 6.875

9.  Urinary excretion of methaqualone-N-oxide in man.

Authors:  C N Reynolds; K Wilson; D Burnett
Journal:  Xenobiotica       Date:  1976-02       Impact factor: 1.908

10.  Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans.

Authors:  R Herz; H R Koelz; U P Haemmerli; I Benes; A L Blum
Journal:  Eur J Clin Invest       Date:  1978-02       Impact factor: 4.686

View more
  7 in total

1.  Influence of menstrual cycle on antipyrine pharmacokinetics in healthy Indian female volunteers.

Authors:  V K Nayak; N A Kshirsagar; N K Desai; R S Satoskar
Journal:  Br J Clin Pharmacol       Date:  1988-11       Impact factor: 4.335

2.  Salivary paracetamol elimination kinetics during the menstrual cycle.

Authors:  L Somaja; J Thangam
Journal:  Br J Clin Pharmacol       Date:  1987-03       Impact factor: 4.335

3.  Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids.

Authors:  E C Rietveld; M M Broekman; J J Houben; T K Eskes; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.

Authors:  A D Kashuba; A N Nafziger
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 5.  Sex-related differences in drug disposition in man.

Authors:  K Wilson
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

6.  The effect of age on the competitive C- and N-oxidative pathways of methaqualone in women.

Authors:  K Wilson; M Oram; D Burnett
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Oct-Dec       Impact factor: 2.441

7.  The influence of the menstrual cycle on the metabolism and clearance of methaqualone.

Authors:  K Wilson; M Oram; C E Horth; D Burnett
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.